Is Foundayo Safe Long Term What The Clinical Trial Data Actually Shows
April 3, 2026
Foundayo (orforglipron) represents the first oral GLP-1 receptor agonist approved for type 2 diabetes, offering patients an alternative to daily injections. However, [...]